Strata Skin Sciences Q2 EPS $(0.09) Misses $(0.05) Estimate, Sales $8.25M Miss $8.74M Estimate
Portfolio Pulse from mahesh@benzinga.com
Strata Skin Sciences (NASDAQ:SSKN) reported Q2 losses of $(0.09) per share, missing the analyst consensus estimate of $(0.05) by 80%. The company also reported quarterly sales of $8.25 million, missing the analyst consensus estimate of $8.74 million by 5.61%. This represents a decrease in both earnings and sales compared to the same period last year.
August 09, 2023 | 8:18 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Strata Skin Sciences reported lower than expected Q2 earnings and sales, which could negatively impact the stock price.
Strata Skin Sciences reported Q2 earnings and sales that were lower than analyst estimates. This could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100